Please use this identifier to cite or link to this item:
https://scidar.kg.ac.rs/handle/123456789/13065
Title: | A comparative study on dispersed doses during photon and proton radiation therapy in pediatric applications |
Authors: | Shahmohammadi Beni M. Krstic, Dragana Nikezic, Dragoslav Yu K. |
Issue Date: | 2021 |
Abstract: | The Monte Carlo method was employed to simulate realistic treatment situations for photon and proton radiation therapy for a set of Oak Ridge National Laboratory (ORNL) pediatric phantoms for 15, 10, 5 and 1-year olds as well as newborns. Complete radiotherapy situations were simulated using the previously developed NRUrad input code for Monte Carlo N-Particle (MCNP) code package. Each pediatric phantom was irradiated at five different positions, namely, the testes, colon, liver, left lung and brain, and the doses in targeted organs (Dt) were determined using the track length estimate of energy. The dispersed photon and proton doses in non-Targeted organs (Dd), namely, the skeleton, skin, brain, spine, left and right lungs were computed. The conversion coefficients (F = Dd/Dt) of the dispersed doses were used to study the dose dispersion in different non-Targeted organs for phantoms for 15, 10, 5 and 1-year olds as well as newborns. In general, the F values were larger for younger patients. The F values for non-Targeted organs for phantoms for 1-year olds and newborns were significantly larger compared to those for other phantoms. The dispersed doses from proton radiation therapy were also found to be significantly lower than those from conventional photon radiation therapy. For example, the largest F values for the brain were 65.6% and 0.206% of the dose delivered to the left lung (P4) for newborns during photon and proton radiation therapy, respectively. The present results demonstrated that dispersion of photons and generated electrons significantly affected the absorbed doses in non-Targeted organs during pediatric photon therapy, and illustrated that proton therapy could in general bring benefits for treatment of pediatric cancer patients. |
URI: | https://scidar.kg.ac.rs/handle/123456789/13065 |
Type: | article |
DOI: | 10.1371/journal.pone.0248300 |
SCOPUS: | 2-s2.0-85102621316 |
Appears in Collections: | Faculty of Science, Kragujevac |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
10.1371-journal.pone.0248300.pdf | 6.15 MB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License